AIG
TBPH icon

American International Group’s Theravance Biopharma TBPH Stock Holding History

American International Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,942
Closed -$215K – 2424
2024
Q1 		$215K Sell
23,942
-1,668
-7% -$15.5K ﹤0.01% 2105
2023
Q4 		$288K Sell
25,610
-2,530
-9% -$25.5K ﹤0.01% 1965
2023
Q3 		$243K Sell
28,140
-1,548
-5% -$14.9K ﹤0.01% 2019
2023
Q2 		$307K Sell
29,688
-1,828
-6% -$20.2K ﹤0.01% 1937
2023
Q1 		$342K Buy
31,516
+626
+2% +$6.62K ﹤0.01% 1809
2022
Q4 		$347K Buy
30,890
+322
+1% +$3.38K ﹤0.01% 1803
2022
Q3 		$310K Buy
30,568
+432
+1% +$4.05K ﹤0.01% 1874
2022
Q2 		$273K Buy
30,136
+346
+1% +$3.19K ﹤0.01% 1974
2022
Q1 		$285K Sell
29,790
-2,097
-7% -$20.5K ﹤0.01% 2032
2021
Q4 		$352K Sell
31,887
-953
-3% -$8.31K ﹤0.01% 2033
2021
Q3 		$243K Buy
32,840
+2,967
+10% +$33.2K ﹤0.01% 2313
2021
Q2 		$434 Buy
29,873
+2,685
+10% +$50.4K ﹤0.01% 2011
2021
Q1 		$555 Buy
27,188
+72
+0.3% +$1.37K ﹤0.01% 1772
2020
Q4 		$482 Sell
27,116
-389
-1% -$6.98K ﹤0.01% 1768
2020
Q3 		$407K Sell
27,505
-626
-2% -$11.7K ﹤0.01% 1696
2020
Q2 		$590K Sell
28,131
-903
-3% -$23.2K ﹤0.01% 1517
2020
Q1 		$671K Buy
29,034
+1,036
+4% +$25.9K ﹤0.01% 1289
2019
Q4 		$725K Buy
27,998
+76
+0.3% +$1.48K ﹤0.01% 1493
2019
Q3 		$544K Sell
27,922
-196
-0.7% -$3.96K ﹤0.01% 1609
2019
Q2 		$459K Buy
28,118
+515
+2% +$10.4K ﹤0.01% 1754
2019
Q1 		$626K Sell
27,603
-895
-3% -$22.7K ﹤0.01% 1574
2018
Q4 		$729K Buy
28,498
+69
+0.2% +$1.86K ﹤0.01% 1448
2018
Q3 		$929K Buy
28,429
+513
+2% +$14K ﹤0.01% 1482
2018
Q2 		$633K Buy
27,916
+847
+3% +$20.1K ﹤0.01% 1678
2018
Q1 		$656K Sell
27,069
-1,065
-4% -$29.2K ﹤0.01% 1524
2017
Q4 		$785K Buy
28,134
+134
+0.5% +$3.96K ﹤0.01% 1510
2017
Q3 		$959K Buy
28,000
+2,094
+8% +$68.5K ﹤0.01% 1375
2017
Q2 		$1.03M Buy
25,906
+1,630
+7% +$62.7K ﹤0.01% 1273
2017
Q1 		$894K Buy
24,276
+3,417
+16% +$109K ﹤0.01% 1256
2016
Q4 		$665K Sell
20,859
-54
-0.3% -$1.68K ﹤0.01% 1468
2016
Q3 		$758K Buy
20,913
+32
+0.2% +$891 ﹤0.01% 1375
2016
Q2 		$474K Buy
20,881
+5,946
+40% +$128K ﹤0.01% 1615
2016
Q1 		$281K Hold
14,935
– – ﹤0.01% 2473
2015
Q4 		$245K Sell
14,935
-26
-0.2% -$413 ﹤0.01% 2634
2015
Q3 		$164K Buy
14,961
+17
+0.1% +$216 ﹤0.01% 3010
2015
Q2 		$195K Buy
14,944
+149
+1% +$2.31K ﹤0.01% 3033
2015
Q1 		$257K Hold
14,795
– – ﹤0.01% 2732
2014
Q4 		$221K Sell
14,795
-584
-4% -$10.2K ﹤0.01% 2863
2014
Q3 		$354K Sell
15,379
-12
-0.1% -$348 ﹤0.01% 2438
2014
Q2 		$491K Buy
+15,391
New +$463K ﹤0.01% 2194

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

American International Group's TBPH Position: Q2 2024 in Review

American International Group sold out of Theravance Biopharma (TBPH) in Q2 2024, closing a stake of 23,942 shares — an estimated $215K sold.

American International Group first reported a position in TBPH in Q2 2014 and held it in 40 quarters. The position peaked at $1.03M in Q2 2017. 132 funds tracked by Wall St. Rank hold TBPH as of Q2 2024.

  • American International Group reported no remaining Theravance Biopharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 23,942 Theravance Biopharma shares in Q2 2024, an estimated $215K.
  • American International Group first reported a position in Theravance Biopharma in Q2 2014 and held it in 40 quarters.
  • American International Group's Theravance Biopharma position peaked at $1.03M in Q2 2017.
  • 132 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.